Latest Stock Advice
Sun Life Financial Inc. and Manulife Financial Corp. each offers a combination of solid earnings growth, ongoing share repurchases, and impressive dividend yields.
Groupe Dynamite Inc. is a high‑quality specialty retailer with gains ahead.
Teck Resources Ltd. is a solid bet on higher copper prices with its big merger winning approvals
Toromont Industries Ltd. should see continued earnings growth thanks to its leading market share and Canada’s plan to increase spending on infrastructure projects.
Become a Successful Investor
How to identify the top copper mining stocks—and how to best to fit them into your portfolio
A Member of Pat McKeough’s Inner Circle asked for his advice on an ETF that focuses on Canadian finance firm common shares, preferred shares and corporate bonds.
Pat likes the high distribution rate but warns that rate may be unsustainable....
Pat likes the high distribution rate but warns that rate may be unsustainable....
Penny stock investing is for gamblers. We think you are better off using these alternative financial planning tips to prepare for the long haul.
Dun & Bradstreet Corp. boosted its dividend for the tenth year in a row after selling some operations and buying back a former holding.
Energy sector stocks can round out any well balanced portfolio—and there is a crucial role they can play
MONSANTO CO., $85.89, New York symbol MON, develops and sells technology-based agricultural products, such as genetically modified seeds, to farmers, grain processors and food companies. It also sells weed- and pest-control products.
The stock fell 5% this week after the company cut its earnings forecast for the current fiscal year. That’s mainly because the high U.S. dollar is hurting the contribution of its overseas sales. As well, lower crop prices give farmers less cash to spend on seeds and pesticides.
For its 2016 fiscal year, which ends August 31, 2016, Monsanto expects to earn $4.40 to $5.10 a share, excluding unusual items. That’s down from its earlier forecast $5.10 to $5.60.
The stock now trades at 18.1 times the midpoint of Monsanto’s new range. That’s a reasonable p/e in light of the worldwide need for more and better food. Moreover, Monsanto spends over 10% of its revenue on research, so it’s more profitable than it seems.
OUR RECOMMENDATION: Monsanto is still a buy.
...
The stock fell 5% this week after the company cut its earnings forecast for the current fiscal year. That’s mainly because the high U.S. dollar is hurting the contribution of its overseas sales. As well, lower crop prices give farmers less cash to spend on seeds and pesticides.
For its 2016 fiscal year, which ends August 31, 2016, Monsanto expects to earn $4.40 to $5.10 a share, excluding unusual items. That’s down from its earlier forecast $5.10 to $5.60.
The stock now trades at 18.1 times the midpoint of Monsanto’s new range. That’s a reasonable p/e in light of the worldwide need for more and better food. Moreover, Monsanto spends over 10% of its revenue on research, so it’s more profitable than it seems.
OUR RECOMMENDATION: Monsanto is still a buy.
...